Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

The value of blood serotonin for effective weight loss in obese women

Cover Page

Abstract


Introduction. Obesity is a disorder of energy balance, which leads to excessive accumulation of fat. In recent years, many important discoveries were made in this field, including the discovery of hormones produced by adipose tissue and the identification of many of the central and peripheral pathways of energy balance.

Objective. To study the levels of hormones that affect appetite and metabolism in women with obesity baseline and after weight loss while taking sibutramine.

Materials and methods. The study included 56 women aged 42,9±9,5 years, with a BMI of 34,6±6,1 kg/m2. All patients underwent clinical, laboratory and instrumental examination. Hormonal study included determination of serotonin, leptin, ghrelin, endothelin-1, adiponectin.

Results: In women with obesity we identified hyperleptinemia and increased serotonin levels. The decrease in body weight in patients receiving sibutramine was accompanied by lower levels of serotonin, leptin, ghrelin, endothelin-1, and increase of adiponectin.

Conclusions: Obese patients have significantly elevated levels of leptin, serotonin, ghrelin compared to women of normal weight. Sibutramine treatment leads to a decrease in serotonin, leptin, ghrelin and is more effective in women with a BMI less than 36,5 kg/m2.


Natal'ya Vadimovna Anikina

Perm State Medical University named after Academician EA Vagner

Author for correspondence.
Email: gigabit07@mail.ru

Russian Federation Assistant of the Department of Endocrinology and Clinical Pharmacology

Elena Nikolaevna Smirnova

Perm State Medical University named after Academician EA Vagner

Email: gigabit07@mail.ru

Russian Federation Sc.D., prof., Head of the Department of Endocrinology and Clinical Pharmacology

  1. Ройтберг Г.Е. Метаболический синдром. – М.: МЕД-пресс-Информ; 2007. [Roytberg GE. Metabolicheskiy sindrom. Moscow: MED-press-Inform; 2008. (In Russ)]
  2. Ожирение: этиология, патогенез, клинические аспекты: Руководство для врачей. / Под ред. Дедова И.И., Мельниченко Г.А.. – М.: Медицинское информационное агентство; 2004. [Ozhirenie: etiologiya, patogenez, klinicheskie aspekty: Rukovodstvo dlya vrachey. Ed by. Dedov II, Mel'nichenko GA. Moscow: Meditsinskoe informatsionnoe agentstvo; 2004. (In Russ)]
  3. Верин В.К., Иванов В.В. Гормоны и их эффекты. – Санкт-Петербург: Фолиант; 2012. [Verin VK, Ivanov VV. Gormony i ikh effekty. Saint Peterburg: Foliant; 2012. (In Russ)]
  4. Каракулова Ю.В. Головная боль напряжения. – Пермь:; 2008. [Karakulova YuV. Golovnaya bol' napryazheniya. Perm; 2008.]
  5. Yildiz BO, Suchard MA, Wong M-L, McCann SM, Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(28):10434-9.

Supplementary files

There are no supplementary files to display.

Views

Abstract - 1030

PDF (Russian) - 1101

Cited-By



Copyright (c) 2015 Аникина Н.В., Смирнова Е.Н.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.